首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Abeta aggregation inhibitors. Part 1: Synthesis and biological activity of phenylazo benzenesulfonamides.
【24h】

Abeta aggregation inhibitors. Part 1: Synthesis and biological activity of phenylazo benzenesulfonamides.

机译:Abeta聚集抑制剂。第1部分:苯偶氮苯磺酰胺的合成和生物活性。

获取原文
获取原文并翻译 | 示例
           

摘要

Phenylazo benzenesulfonamides were designed and synthesized as beta-amyloid (Abeta40) fibril assembly inhibitors, and evaluated for inhibition of Abeta40 aggregation and neurotoxicity using rat cortical neurons. Compound 2 (LB-152) was the most potent compound in this study, and the para-NMe(2) group on the end of the phenylazo moiety may play an important role in preventing Abeta40 fibril formation. LB-152 provides a new lead for further development of potential beta-amyloid aggregation inhibitors to treat AD.
机译:设计并合成了苯基偶氮苯磺酰胺作为β-淀粉样蛋白(Abeta40)原纤维组装抑制剂,并使用大鼠皮层神经元评估了对Abeta40聚集和神经毒性的抑制作用。化合物2(LB-152)是这项研究中最有效的化合物,苯基偶氮部分末端的对NMe(2)基团可能在防止Abeta40原纤维形成中起重要作用。 LB-152为进一步开发治疗AD的潜在β-淀粉样蛋白聚集抑制剂提供了新的线索。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号